The Journal of Urology
Volume 181, Issue 3 , Page 1113, March 2009

Editorial Comment

Oregon Health & Science University Cancer Institute, Portland, Oregon

published online 23 January 2009.

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-5347(08)03340-5

doi:10.1016/j.juro.2008.11.137

Refers to article:

  • A Double-Blind Randomized Crossover Study of Oral Thalidomide Versus Placebo for Androgen Dependent Prostate Cancer Treated With Intermittent Androgen Ablation , 23 January 2009

    William D. Figg, Maha H. Hussain, James L. Gulley, Philip M. Arlen, Jeanny B. Aragon-Ching, Daniel P. Petrylak, Celestia S. Higano, Seth M. Steinberg, Gurkamal S. Chatta, Howard Parnes, John J. Wright, Oliver Sartor, William L. Dahut
    The Journal of Urology March 2009 (Vol. 181, Issue 3, Pages 1104-1113)

The Journal of Urology
Volume 181, Issue 3 , Page 1113, March 2009

Article Tools